MAPK6 and cancer: Furthermore, our results align with previous reports using mouse models, in which injection of MDA-MB231 cell lines with or without ERK3 knockdown showed that ERK3 knockdown reduced overall tumour burden, cancer cell migration, and lung colonisation capacity (14, 15).